Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (12) , 1658-1663
- https://doi.org/10.1016/0959-8049(93)90099-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prospective Multicenter Phase-Ill Trial of Doxifluridine (5’dFUR) versus 5-Fluorouracil in Patients with Advanced Colorectal CarcinomaOncology Research and Treatment, 1991
- Phase I–II trial of doxifluridine (5′DFUR) administered as long-term continuous infusion using a portable infusion pump for advanced colorectal cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- A randomized comparison of doxifluridine and fluorouracil in colorectal carcinomaEuropean Journal of Cancer and Clinical Oncology, 1988
- Doxifluridine (5?-dFUrd) in patients with advanced colorectal carcinomaCancer Chemotherapy and Pharmacology, 1985
- Phase II study of doxifluridine in advanced colorectal adenocarcinoma.Journal of Clinical Oncology, 1983
- Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridinePublished by Elsevier ,1980
- Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosidesJournal of Medicinal Chemistry, 1979
- Chemotherapy of Gastrointestinal CancerNew England Journal of Medicine, 1978
- A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary reportCancer, 1977
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957